Add office photos
Employer?
Claim Account for FREE
Pfizer
4.0
based on 1.8k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Pfizer
Company Summary
Pfizer is one of the world's premier biopharmaceutical companies.
Overall Rating
4.0/5
based on 1.8k reviews
3% above
industry average
Highly rated for
Work-life balance, Company culture, Skill development
Critically rated for
Promotions
Work Policy
Work from office
55% employees reported
Monday to Friday
41% employees reported
Flexible timing
68% employees reported
Within city
38% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
218 employees reported
Health insurance
213 employees reported
Office cab/shuttle
161 employees reported
Cafeteria
121 employees reported
View all benefits
About Pfizer
Founded in2004 (21 yrs old)
India Employee Count5k-10k
Global Employee Count1 Lakh+
India HeadquartersChennai, Tamil Nadu, India
Office Locations
Websitepfizer.com
Primary Industry
Other Industries
Are you managing Pfizer's employer brand? To edit company information,
claim this page for free
View in video summary
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.
Managing your company's employer brand?
Claim this Company Page for FREE
Pfizer Ratings
based on 1.8k reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
999
4
447
3
169
2
67
1
102
Category Ratings
4.0
Work-life balance
3.9
Company culture
3.8
Skill development
3.7
Salary
3.6
Work satisfaction
3.4
Job security
3.1
Promotions
Pfizer is rated 4.0 out of 5 stars on AmbitionBox, based on 1.8k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Pfizer
based on 1.7k reviews
4.1
Rated by 225 Women
Rated 4.2 for Work-life balance and 4.2 for Company culture
4.0
Rated by 1.4k Men
Rated 4.0 for Work-life balance and 3.8 for Company culture
Work Policy at Pfizer
based on 133 reviews in last 6 months
Work from office
55%
Hybrid
40%
Permanent work from home
5%
Pfizer Reviews
Top mentions in Pfizer Reviews
+ 5 more
Compare Pfizer with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 1.8k reviews | 4.0/5 based on 6.9k reviews | 4.1/5 based on 1.8k reviews | 4.1/5 based on 7k reviews |
Highly Rated for | Work-life balance Company culture Skill development | Skill development Company culture Work-life balance | Company culture Skill development Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | Promotions | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 55% employees reported | Work from office 73% employees reported | Hybrid 71% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 4.1 Good rated by 225 women | 4.0 Good rated by 767 women | 4.1 Good rated by 280 women | 4.0 Good rated by 693 women |
Rating by Men Employees | 4.0 Good rated by 1.4k men | 4.1 Good rated by 5.8k men | 4.1 Good rated by 1.5k men | 4.1 Good rated by 5.9k men |
Job security | 3.4 Average | 3.6 Good | 3.7 Good | 3.7 Good |
View more
Pfizer Salaries
Pfizer salaries have received with an average score of 3.7 out of 5 by 1.8k employees.
Territory Executive
(318 salaries)
Unlock
₹3.2 L/yr - ₹8.3 L/yr
Junior Officer
(256 salaries)
Unlock
₹1.8 L/yr - ₹3.6 L/yr
Junior Associate
(150 salaries)
Unlock
₹2 L/yr - ₹3.6 L/yr
Health Care Executive
(146 salaries)
Unlock
₹3.6 L/yr - ₹9.7 L/yr
District Business Manager
(129 salaries)
Unlock
₹7.6 L/yr - ₹21.4 L/yr
Medical Representative
(80 salaries)
Unlock
₹2 L/yr - ₹8.1 L/yr
Assistant Officer
(79 salaries)
Unlock
₹3 L/yr - ₹4.5 L/yr
Senior Territory Executive
(79 salaries)
Unlock
₹5.1 L/yr - ₹10.5 L/yr
Assistant Associate
(79 salaries)
Unlock
₹3 L/yr - ₹5.5 L/yr
Team Lead
(75 salaries)
Unlock
₹4.2 L/yr - ₹14 L/yr
Pfizer Interview Questions
Interview questions by designation
Top Pfizer interview questions and answers
Get interview-ready with top interview questions
Pfizer Jobs
Popular Designations Pfizer Hires for
Popular Skills Pfizer Hires for
Current Openings
Pfizer News
View all
ACMG Foundation for Genetic and Genomic Medicine to Unveil Four Next-Generation Fellowship Awards at 2025 Annual Clinical Genetics Meeting
- The ACMG Foundation for Genetic and Genomic Medicine annually awards the Next Generation Fellowship to early career professionals in medical genetics and genomics.
- The fellowship covers specialties such as Clinical Genetics, Clinical Biochemical Genetics, Laboratory Genetics and Genomics, Medical Biochemical Genetics, and Ophthalmic Genetics.
- Corporate sponsors like Bionano, Pfizer, Sanofi, Spark Therapeutics, and Takeda support the development of future leaders in genetic and genomic medicine.
- The 2025 recipients, including Rafael Garrett da Costa, Atlas Sardoo, Emily S. Levine, and Daniel R. Brooks, showcase dedication to advancing genomics.
- Dr. Garrett da Costa specializes in mass spectrometry and metabolomics, focusing on rare metabolic disorders and diagnostic methodologies.
- Dr. Sardoo's work at NIH links viral infections and liver cancer, uniting bioinformatics with clinical practices.
- Dr. Levine, specializing in ophthalmic genetics, aims to enhance care for patients with genetic eye conditions.
- Dr. Brooks, advocating for genetic healthcare accessibility, highlights issues like prenatal diagnostics and rare genetic conditions.
- The ACMG Foundation supports burgeoning clinician-scientists to transform genomic insights into healthcare advancements.
- The fellowship recipients exemplify a commitment to inclusivity, equity, and innovation in medical genetics and genomics.
Bioengineer | 19 Mar, 2025
Nvidia’s GTC 2025 will feature AI’s brightest minds and draw 25K attendees in person
- Nvidia announced GTC 2025 with 25,000 in-person attendees and 300,000 virtual attendees set to take place in San Jose, California.
- CEO Jensen Huang's keynote will be held at SAP Center on March 18 at 10 a.m. Pacific time, focusing on AI and accelerated computing technologies.
- The event will be livestreamed on nvidia.com, and registration is not required to view the keynote online.
- GTC will feature over 1,000 sessions, 2,000 speakers, and almost 400 exhibitors showcasing AI's impact across industries.
- Attendees can explore demos, hands-on training, autonomous vehicle exhibits, and a GTC Night Market with local vendors and artisans.
- Notable speakers include Pieter Abbeel, Frances Arnold, Yann LeCun, and Jeffrey Katzenberg, among others.
- More than 900 organizations will participate, including Accenture, Meta, Microsoft, MLB, NFL, Pfizer, Salesforce, Uber, and Volkswagen.
- Nvidia will host its first Quantum Day on March 20, bringing together the quantum computing community with industry leaders.
- GTC will offer hands-on workshops, certification exams, AI Day for startups and VCs, and showcase innovative startups through Nvidia Inception Pavilion.
- Investors can join a Q&A session on March 19, and the event will provide networking opportunities and valuable insights into AI and accelerated computing.
VentureBeat | 6 Mar, 2025
Avoid these Two Stocks
- Investors who avoided the post-pandemic stocks should continue to do so.
- Teladoc Health (TDOC) has no growth potential and experienced a significant loss.
- Moderna (MRNA) is at risk of falling to the $25 level and may lose government funding for bird flu vaccine development.
- The government may choose other companies like GSK (GSK), Sanofi (SNY), CureVac (CVAC), or Pfizer (PFE) for the bird flu vaccine development.
Baystreet | 5 Mar, 2025
Anthropic raises $3.5 billion, reaching $61.5 billion valuation as AI investment frenzy continues
- Anthropic has raised $3.5 billion in a Series E funding round, leading to a post-money valuation of $61.5 billion.
- The funding was led by Lightspeed Venture Partners with a significant contribution, showcasing the strong demand for AI investments.
- Investors like Salesforce Ventures, Cisco Investments, and many others participated in this financing round.
- The investment will propel Anthropic's AI systems development, research expansion, and global reach.
- Anthropic's revenue soared to $1 billion by December 2024, with a subsequent 30% surge in the first two months of 2025.
- Established in 2021, Anthropic distinguishes itself with its research-driven approach and safety focus in AI development.
- The company's chatbot, Claude, has gained prominence in enterprise sectors since its launch in 2023.
- Investors believe in AI's transformative potential, evident in Anthropic's high valuation multiples despite challenges in traditional valuation models.
- Major tech players like Amazon and Google have made significant investments in Anthropic, focusing on deploying large AI models.
- The company's B2B strategy has attracted clients like Zoom, Snowflake, and Pfizer, showcasing its market appeal.
VentureBeat | 4 Mar, 2025
Amazon-backed AI firm Anthropic valued at $61.5 billion after latest round
- Anthropic has closed its latest funding round at a $61.5 billion post-money valuation, led by Lightspeed Venture Partners.
- The artificial intelligence startup plans to expand its compute capacity, deepen research, and accelerate international expansion.
- Anthropic's revenue hit $1 billion annually, primarily from enterprise sales, with clients including Zoom, Pfizer, and Amazon's Alexa+.
- Generative AI market, including Anthropic and OpenAI, is predicted to exceed $1 trillion in revenue within a decade.
CNBC | 4 Mar, 2025
How I Earned My AWS Developer Associate Certification
- Achieving the AWS Certified Developer — Associate certification was a significant milestone in my career as a software developer.
- The decision to pursue the AWS Certified Developer — Associate certification was driven by the increasing adoption of cloud computing by companies.
- Amazon Web Services (AWS) serves approximately 4.19 million customers globally, including companies like Netflix, Airbnb, Coca-Cola, BMW, Samsung, General Electric, Pfizer, and NASA.
- Tips for achieving the certification include accessing the official exam guide, studying through courses with explanatory videos and hands-on examples, and practicing with practice tests.
Medium | 28 Feb, 2025
Pfizer Share Price Jumps After Pact With Mylan Pharmaceuticals
- Pfizer's share price rose over 8% after signing a sales and marketing pact with Mylan Pharmaceuticals.
- Pfizer will conduct marketing and sales of Mylan's brands, Ativan and Pacitane, in India for a period of five years.
- In the third quarter of the current fiscal year, Pfizer's net profit fell by 2%, while revenues and margins also decreased.
- Pfizer's share price reached its highest level since Feb. 7, rising 8.52% to Rs 4,444 apiece.
Bloomberg Quint | 24 Feb, 2025
Pfizer v. Softgel: The Errors of Comity
- The Madras High Court passed an order related to an ongoing patent dispute concerning Cipla’s and Zenara's ANDA applications seeking approval to market generic versions of Vyndamax in the US against Pfizer's US patent.
- Pfizer requested a Letter Rogatory to the Madras High Court for assistance in obtaining documents from an Indian company, Softgel Healthcare Private Limited, to be used in the proceedings.
- The Madras High Court upheld the principle of judicial assistance but failed to thoroughly check the information sought in the Letter Rogatory.
- A Letter Rogatory is a request for judicial assistance between courts of different countries, based on the principle of comity.
- Pfizer sought assistance from the Madras High Court to collect information and establish a confidentiality club, while Softgel opposed disclosure citing reasons like not being a party to the US suit and TRIPS regulations.
- The Madras High Court disregarded Softgel's arguments, dismissed concerns regarding the vagueness of information sought, and accepted the Letter Rogatory without fully understanding the information requested.
- The Court's decision raises questions about directing the collection of evidence from non-parties and the importance of assessing the relevance of documents, unlike the approach in the US courts.
- The US courts have additional qualifiers, including specificity, to determine requests for document discovery, unlike the Madras High Court's approach that prioritized upholding comity with the US court.
- The order by the Madras High Court could significantly impact the dispute's outcome, potentially affecting access to drugs like Vyndamax in the US which are priced at around $23,324 for a supply of 30 capsules.
Spicyip | 23 Feb, 2025
Kore.ai’s No-Code Agents are Out to Democratise AI Developments
- Kore.ai offers a no-code platform for building and deploying AI agents.
- The platform allows the development of AI agents without extensive coding knowledge.
- Kore.ai's AI agents have made significant impacts across industries, including banking and healthcare.
- Kore.ai is addressing challenges of deploying AI agents at scale through built-in agent evaluation services.
Analyticsindiamag | 12 Feb, 2025
PayPal, Pfizer, and Merck Stocks Are On Sale
- PayPal, Pfizer, and Merck stocks fell after disappointing investors due to various factors.
- PayPal's revenue increased by 5% YoY to $8.4 billion. However, net income declined by 20% to $1.1 billion.
- Pfizer reported a 25% YoY revenue increase to $17.8 billion, but shareholders are not pleased with the current buyback authorization.
- Merck & Co. experienced a 9.07% stock drop after posting a weak outlook and temporarily pausing shipments of its HPV vaccine.
Baystreet | 5 Feb, 2025
Powered by
Pfizer Subsidiaries
Baxter International
4.0
• 652 reviews
Pfizer Products India
4.1
• 292 reviews
Innopark
3.6
• 19 reviews
Parke Davis
4.5
• 2 reviews
Alacer
2.2
• 2 reviews
PHARMACIA AND UPJOHN INDIA
5.0
• 1 review
Report error
Compare Pfizer with
Sun Pharmaceutical Industries
4.0
Biocon Limited
3.9
Aurobindo Pharma
4.0
Lupin
4.2
Zydus Lifesciences
4.1
Torrent Pharmaceuticals
3.9
DIVI'S Laboratories
3.7
Alembic Pharmaceuticals
4.0
Abbott
4.1
Glenmark Pharmaceuticals
3.9
Alkem Laboratories
3.9
Ipca Laboratories
3.9
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.4
Cadila Pharmaceuticals
3.5
Laurus Labs
4.2
Wockhardt
3.9
Granules India
3.8
Sanofi
4.2
Indoco Remedies
3.6
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Pfizer
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.8k reviews
Cipla
Manufacturing, Pharma
4.1
• 7k reviews
Dr. Reddy's
Clinical Research, Pharma
4.0
• 6.9k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.8k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6.1k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 6k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
DIVI'S Laboratories
Pharma
3.7
• 1.4k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.1k reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.1k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.9k reviews
Pfizer FAQs
When was Pfizer founded?
Pfizer was founded in 2004. The company has been operating for 21 years primarily in the Pharma sector.
Where is the Pfizer headquarters located?
Pfizer is headquartered in Chennai, Tamil Nadu. It operates in 4 cities such as Mumbai, Chennai, Kolkata, Gurgaon / Gurugram. To explore all the office locations, visit Pfizer locations.
How many employees does Pfizer have in India?
Pfizer currently has more than 5,500+ employees in India. Research & Development department appears to have the highest employee count in Pfizer based on the number of reviews submitted on AmbitionBox.
Does Pfizer have good work-life balance?
Pfizer has a work-life balance rating of 4.0 out of 5 based on 1,700+ employee reviews on AmbitionBox. 81% employees rated Pfizer 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read Pfizer work-life balance reviews for more details
Is Pfizer good for career growth?
Career growth at Pfizer is rated as moderate, with a promotions and appraisal rating of 3.1. 19% employees rated Pfizer 3 or below, while 81% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Pfizer promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Pfizer?
Working at Pfizer comes with several advantages and disadvantages. It is highly rated for work life balance, company culture and skill development. However, it is poorly rated for promotions / appraisal, based on 1,700+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
